Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Bauer, H. Möllmann, F. Weidinger, U. Zeymer, R. Seabra‐Gomes, F. Eberli, P. Serruys, A. Vahanian, S. Silber, W. Wijns, M. Hochadel, H. Nef, C. Hamm, J. Marco, A. Gitt (2011)
Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina.International journal of cardiology, 151 2
D. Cutlip, S. Windecker, R. Mehran, A. Boam, D. Cohen, G. Es, P. Steg, M. Morel, L. Mauri, P. Vranckx, E. Mcfadden, A. Lansky, M. Hamon, M. Krucoff, P. Serruys (2007)
Clinical End Points in Coronary Stent Trials: A Case for Standardized DefinitionsCirculation, 115
C. Cannon, R. Harrington, S. James, D. Ardissino, R. Becker, H. Emanuelsson, S. Husted, H. Katus, M. Keltai, N. Khurmi, F. Kontny, B. Lewis, P. Steg, R. Storey, D. Wojdyla, L. Wallentin (2010)
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyThe Lancet, 375
S. Wiviott, E. Braunwald, C. Mccabe, I. Horváth, M. Keltai, J. Herrman, F. Werf, William Downey, B. Scirica, S. Murphy, E. Antman (2008)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trialThe Lancet, 371
G. Biondi‐Zoccai, G. Sangiorgi, A. Chieffo, G. Vittori, E. Falchetti, M. Margheri, R. Barbagallo, C. Tamburino, Enrico Remigi, C. Briguori, I. Iakovou, P. Agostoni, E. Tsagalou, G. Melzi, I. Michev, F. Airoldi, M. Montorfano, M. Carlino, A. Colombo (2005)
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.The American journal of cardiology, 95 12
G. Sianos, Michail Papafaklis, P. Serruys (2010)
Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention.The Journal of invasive cardiology, 22 10 Suppl B
G. Stone, J. Moses, S. Ellis, J. Schofer, K. Dawkins, M. Morice, A. Colombo, E. Schampaert, E. Grube, A. Kirtane, D. Cutlip, M. Fahy, S. Pocock, R. Mehran, M. Leon (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.The New England journal of medicine, 356 10
M. Fokkema, P. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G. Diercks, A. Suurmeijer, F. Zijlstra (2008)
Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction.European heart journal, 30 8
C. Gibson, C. Cannon, S. Murphy, S. Marble, H. Barron, E. Braunwald (2002)
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial InfarctionCirculation: Journal of the American Heart Association, 105
T. Akasaka, K. Yoshida, T. Kawamoto, S. Kaji, Y. Ueda, A. Yamamuro, T. Takagi, T. Hozumi (2000)
Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting.Circulation, 101 20
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. Sangiorgi, G. Stanković, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, A. Colombo (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA, 293 17
A. Chieffo, E. Bonizzoni, D. Orlic, G. Stanković, R. Rogacka, F. Airoldi, G. Mikhail, M. Montorfano, I. Michev, M. Carlino, A. Colombo (2004)
Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting StentsCirculation: Journal of the American Heart Association, 109
A. Hoye, I. Iakovou, L. Ge, Carl-Edward Mieghem, A. Ong, J. Cosgrave, G. Sangiorgi, F. Airoldi, M. Montorfano, I. Michev, A. Chieffo, M. Carlino, N. Corvaja, J. Aoki, G. Granillo, M. Valgimigli, G. Sianos, W. Giessen, A. Colombo (2006)
Clinical ResearchInterventional CardiologyLong-Term Outcomes After Stenting of Bifurcation Lesions With the “Crush” Technique: Predictors of an Adverse OutcomeJournal of the American College of Cardiology, 47
P. Fefer, Amin Daoulah, B. Strauss, R. Chisholm, J. Sparkes, A. Segev (2010)
Visible angiographic complications predict short and long‐term outcomes in patients with post‐procedural creatine‐phosphokinase elevationCatheterization and Cardiovascular Interventions, 76
J. Aoki, A. Lansky, R. Mehran, J. Moses, Michel Bertrand, B. McLaurin, David Cox, A. Lincoff, E. Ohman, Harvey White, H. Parise, Martin Leon, G. Stone (2009)
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy TrialCirculation, 119
L. Ge, F. Airoldi, I. Iakovou, J. Cosgrave, I. Michev, G. Sangiorgi, M. Montorfano, A. Chieffo, M. Carlino, N. Corvaja, A. Colombo (2005)
Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation.Journal of the American College of Cardiology, 46 4
H. Mueller, A. Dyer, M. Greenberg (1985)
The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.The New England journal of medicine, 312 14
Objectives To assess the occurrence, correlation, and clinical outcome of intraprocedural stent thrombosis (IPST) in patients undergoing primary percutaneous coronary intervention (PCI) in the setting of acute coronary syndromes (ACSs). Background Stent thrombosis (ST), a rare complication of PCI, is more common in the setting of ACS. It is not known whether IPST carries the same prognosis as postprocedural ST. Methods This retrospective study comprised a review of 1,901 consecutive ACS patients who received primary PCI in our center from January 2006 to January 2011. IPST was defined as new, reappearing or increased thrombus within the deployed stent before the index PCI procedure was completed. All angiograms were independently reviewed frame by frame for the incidence of IPST. Patients with and without IPST were compared with respect to clinical characteristics, angiographic parameters, and major adverse cardiac events (MACEs) at 30 days and 1‐year follow‐up. Results Overall, there were 23 cases of IPST detected, thus, the prevalence of IPST was 1.2%. There were no significant differences in baseline clinical characteristics between the 2 groups. Patients with compared to those without IPST had significantly more bifurcation lesions involved, and more thrombus burden at baseline. IPST group compared to no IPST group had more MACEs on 30 days (26.1% vs. 8.7%, P = 0.01) and 1‐year follow‐up (30.4% vs. 14.4%, P = 0.02). Conclusions IPST was a rare complication of PCI in the setting of ACS. It correlated with lesion morphology, presence of thrombus at baseline and was more likely to cause MACEs in 30 days and 1‐year follow‐up. (J Interven Cardiol 2013;26:215–220)
Journal of Interventional Cardiology – Wiley
Published: Jun 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.